Sendero Group

Sendero is a private biotechnology company focused on the discovery and development of novel small molecule therapeutics for metabolic and inflammatory diseases. Based in Austin, Texas, the company was founded by a team of experienced drug hunters, including former leadership from Peloton Therapeutics. Sendero is backed by premier venture capital firms, notably The Column Group, and leverages a robust drug discovery platform to identify and optimize candidates for high-value biological targets. The company's mission is to translate complex biology into transformative medicines for patients with limited treatment options. Currently in the pre-clinical stage, Sendero is advancing a pipeline of proprietary programs aimed at modulating key drivers of disease.